BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$691M |
| 2 |
Microsoft
MSFT
|
+$544M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$455M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$429M |
| 5 |
Pfizer
PFE
|
+$421M |
Top Sells
| 1 |
Visa
V
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$590M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$570M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$374M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$340M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Financials | 10.71% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Healthcare | 9.73% |
| 5 | Communication Services | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Sabre
SABR
$738M
| $547K | ﹤0.01% |
149,100
-121,484
| -45% | -$446K |
|
2002
Jack in the Box
JACK
$350M
| $544K | ﹤0.01% |
11,699
+3,754
| +47% | +$175K |
|
2003
Orthofix Medical
OFIX
$589M
| $543K | ﹤0.01% |
34,758
+9,456
| +37% | +$148K |
|
2004
Acadia Realty Trust
AKR
$2.64B
| $539K | ﹤0.01% |
22,969
+253
| +1% | +$5.94K |
|
2005
First Bancorp
FBNC
$2.29B
| $539K | ﹤0.01% |
12,956
+4,838
| +60% | +$201K |
|
2006
Immersion
IMMR
$221M
| $539K | ﹤0.01% |
60,404
-7,243
| -11% | -$64.6K |
|
2007
IMAX
IMAX
$1.74B
| $537K | ﹤0.01% |
26,161
-1,824
| -7% | -$37.4K |
|
2008
Surgery Partners
SGRY
$2.8B
| $536K | ﹤0.01% |
16,616
-84,424
| -84% | -$2.72M |
|
2009
American Superconductor
AMSC
$2.54B
| $535K | ﹤0.01% |
22,679
-24,961
| -52% | -$589K |
|
|
VLRS
2010
Controladora Vuela Compañía de Aviación
VLRS
$694M
| $533K | ﹤0.01% |
84,252
+51,580
| +158% | +$327K |
|
2011
Agios Pharmaceuticals
AGIO
$2.14B
| $531K | ﹤0.01% |
11,946
+1,570
| +15% | +$69.8K |
|
2012
Grifois
GRFS
$6.72B
| $529K | ﹤0.01% |
59,577
-75,576
| -56% | -$671K |
|
2013
Franklin Covey
FC
$240M
| $527K | ﹤0.01% |
12,810
+7,606
| +146% | +$313K |
|
2014
Fresh Del Monte Produce
FDP
$1.71B
| $525K | ﹤0.01% |
17,768
-9,941
| -36% | -$294K |
|
2015
BioLife Solutions
BLFS
$1.22B
| $522K | ﹤0.01% |
20,845
-16,880
| -45% | -$423K |
|
2016
CONMED
CNMD
$1.64B
| $522K | ﹤0.01% |
7,253
-2,472
| -25% | -$178K |
|
2017
Talos Energy
TALO
$1.68B
| $521K | ﹤0.01% |
50,316
+36,356
| +260% | +$376K |
|
2018
S&T Bancorp
STBA
$1.5B
| $520K | ﹤0.01% |
12,396
+4,929
| +66% | +$207K |
|
|
DX
2019
Dynex Capital
DX
$1.63B
| $517K | ﹤0.01% |
40,502
+24,139
| +148% | +$308K |
|
2020
Kimball Electronics
KE
$741M
| $516K | ﹤0.01% |
27,898
+20,385
| +271% | +$377K |
|
2021
ArriVent BioPharma
AVBP
$800M
| $516K | ﹤0.01% |
21,965
+5,397
| +33% | +$127K |
|
2022
Old Second Bancorp
OSBC
$961M
| $514K | ﹤0.01% |
32,967
+24,084
| +271% | +$375K |
|
|
SAGE
2023
DELISTED
Sage Therapeutics
SAGE
| $513K | ﹤0.01% |
70,986
+24,356
| +52% | +$176K |
|
2024
White Mountains Insurance
WTM
$4.54B
| $511K | ﹤0.01% |
301
+202
| +204% | +$343K |
|
2025
Northfield Bancorp
NFBK
$492M
| $508K | ﹤0.01% |
43,809
+35,751
| +444% | +$415K |
|